Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Standard

Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women. / Bjertrup, Anne Juul; Væver, Mette Skovgaard; Miskowiak, Kamilla Woznica.

I: European Neuropsychopharmacology, Bind 73, 08.2023, s. 36-47.

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Harvard

Bjertrup, AJ, Væver, MS & Miskowiak, KW 2023, 'Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women', European Neuropsychopharmacology, bind 73, s. 36-47. https://doi.org/10.1016/j.euroneuro.2023.04.014

APA

Bjertrup, A. J., Væver, M. S., & Miskowiak, K. W. (2023). Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women. European Neuropsychopharmacology, 73, 36-47. https://doi.org/10.1016/j.euroneuro.2023.04.014

Vancouver

Bjertrup AJ, Væver MS, Miskowiak KW. Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women. European Neuropsychopharmacology. 2023 aug.;73:36-47. https://doi.org/10.1016/j.euroneuro.2023.04.014

Author

Bjertrup, Anne Juul ; Væver, Mette Skovgaard ; Miskowiak, Kamilla Woznica. / Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women. I: European Neuropsychopharmacology. 2023 ; Bind 73. s. 36-47.

Bibtex

@article{5e43619488b44d0cb84ad84bba4899ab,
title = "Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women",
abstract = "Postpartum depression (PPD) is a severe mental illness affecting 10–15% of mothers. Emerging evidence indicates that negative neurocognitive bias in response to infant distress during pregnancy marks an increased risk of PPD. This proof-of-concept study aimed to investigate the association between negatively biased neurocognitive processing of infant distress during pregnancy and subsequent PPD and to explore the feasibility of an online risk screening tool. In the second or third trimester of pregnancy, 87 participants underwent two online tests of reactivity to and evaluation of infant distress and completed questionnaires regarding psychosocial risk factors. After birth, participants rated their depressive symptoms online and underwent a diagnostic telephone interview concerning PPD. Irrespective of depressive symptoms during pregnancy, negative reactivity to and evaluation of infant distress predicted PPD (reactivity: Exp(B)=1.33, p = 0.04) and depressive symptoms after birth (reactivity: B = 0.04, p = 0.048; evaluation: B = 0.10, p = 0.04). The negative reactivity toward infant distress showed high sensitivity and moderate specificity (89% and 77%, respectively), while the evaluation of infant distressed cries showed lower sensitivity and specificity (67% and 66%, respectively). The relatively small sample size prevented the inclusion of additional risk variables in the regression models. The replication of an association between negative neurocognitive bias during pregnancy with PPD risk is noteworthy and has clinical implications in terms of early prevention. However, the low response rate indicates that this tool is not feasible in its current form. Future larger-scale studies are needed to further investigate candidate risk factors in a brief online screening tool.",
keywords = "Emotion regulation, Emotions, Mass screening, Neurocognitive tests, Postpartum depression, Pregnancy",
author = "Bjertrup, {Anne Juul} and V{\ae}ver, {Mette Skovgaard} and Miskowiak, {Kamilla Woznica}",
note = "Publisher Copyright: {\textcopyright} 2023 The Author(s)",
year = "2023",
month = aug,
doi = "10.1016/j.euroneuro.2023.04.014",
language = "English",
volume = "73",
pages = "36--47",
journal = "European Neuropsychopharmacology",
issn = "0924-977X",
publisher = "Elsevier",

}

RIS

TY - JOUR

T1 - Prediction of postpartum depression with an online neurocognitive risk screening tool for pregnant women

AU - Bjertrup, Anne Juul

AU - Væver, Mette Skovgaard

AU - Miskowiak, Kamilla Woznica

N1 - Publisher Copyright: © 2023 The Author(s)

PY - 2023/8

Y1 - 2023/8

N2 - Postpartum depression (PPD) is a severe mental illness affecting 10–15% of mothers. Emerging evidence indicates that negative neurocognitive bias in response to infant distress during pregnancy marks an increased risk of PPD. This proof-of-concept study aimed to investigate the association between negatively biased neurocognitive processing of infant distress during pregnancy and subsequent PPD and to explore the feasibility of an online risk screening tool. In the second or third trimester of pregnancy, 87 participants underwent two online tests of reactivity to and evaluation of infant distress and completed questionnaires regarding psychosocial risk factors. After birth, participants rated their depressive symptoms online and underwent a diagnostic telephone interview concerning PPD. Irrespective of depressive symptoms during pregnancy, negative reactivity to and evaluation of infant distress predicted PPD (reactivity: Exp(B)=1.33, p = 0.04) and depressive symptoms after birth (reactivity: B = 0.04, p = 0.048; evaluation: B = 0.10, p = 0.04). The negative reactivity toward infant distress showed high sensitivity and moderate specificity (89% and 77%, respectively), while the evaluation of infant distressed cries showed lower sensitivity and specificity (67% and 66%, respectively). The relatively small sample size prevented the inclusion of additional risk variables in the regression models. The replication of an association between negative neurocognitive bias during pregnancy with PPD risk is noteworthy and has clinical implications in terms of early prevention. However, the low response rate indicates that this tool is not feasible in its current form. Future larger-scale studies are needed to further investigate candidate risk factors in a brief online screening tool.

AB - Postpartum depression (PPD) is a severe mental illness affecting 10–15% of mothers. Emerging evidence indicates that negative neurocognitive bias in response to infant distress during pregnancy marks an increased risk of PPD. This proof-of-concept study aimed to investigate the association between negatively biased neurocognitive processing of infant distress during pregnancy and subsequent PPD and to explore the feasibility of an online risk screening tool. In the second or third trimester of pregnancy, 87 participants underwent two online tests of reactivity to and evaluation of infant distress and completed questionnaires regarding psychosocial risk factors. After birth, participants rated their depressive symptoms online and underwent a diagnostic telephone interview concerning PPD. Irrespective of depressive symptoms during pregnancy, negative reactivity to and evaluation of infant distress predicted PPD (reactivity: Exp(B)=1.33, p = 0.04) and depressive symptoms after birth (reactivity: B = 0.04, p = 0.048; evaluation: B = 0.10, p = 0.04). The negative reactivity toward infant distress showed high sensitivity and moderate specificity (89% and 77%, respectively), while the evaluation of infant distressed cries showed lower sensitivity and specificity (67% and 66%, respectively). The relatively small sample size prevented the inclusion of additional risk variables in the regression models. The replication of an association between negative neurocognitive bias during pregnancy with PPD risk is noteworthy and has clinical implications in terms of early prevention. However, the low response rate indicates that this tool is not feasible in its current form. Future larger-scale studies are needed to further investigate candidate risk factors in a brief online screening tool.

KW - Emotion regulation

KW - Emotions

KW - Mass screening

KW - Neurocognitive tests

KW - Postpartum depression

KW - Pregnancy

U2 - 10.1016/j.euroneuro.2023.04.014

DO - 10.1016/j.euroneuro.2023.04.014

M3 - Journal article

C2 - 37119561

AN - SCOPUS:85153587961

VL - 73

SP - 36

EP - 47

JO - European Neuropsychopharmacology

JF - European Neuropsychopharmacology

SN - 0924-977X

ER -

ID: 346241622